苑东生物
(688513)
| 流通市值：69.22亿 | | | 总市值：69.22亿 |
| 流通股本：1.20亿 | | | 总股本：1.20亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 314,990,089.28 | 1,117,120,749.58 | 849,780,066.91 | 555,357,976.41 |
| 营业收入 | 314,990,089.28 | 1,117,120,749.58 | 849,780,066.91 | 555,357,976.41 |
| 二、营业总成本 | 258,240,843.28 | 951,862,398.84 | 691,107,775.32 | 447,746,528.9 |
| 营业成本 | 63,554,482.38 | 223,274,090.2 | 159,920,603.41 | 99,677,861.65 |
| 税金及附加 | 4,933,061.25 | 17,825,701.97 | 13,437,373.02 | 8,711,732.67 |
| 销售费用 | 115,644,087.01 | 384,561,616.09 | 287,131,932.1 | 190,523,083.65 |
| 管理费用 | 20,868,865.41 | 98,866,793.87 | 71,909,637.24 | 47,759,868.79 |
| 研发费用 | 54,184,914.96 | 238,490,518.55 | 168,765,644.63 | 106,736,616.16 |
| 财务费用 | -944,567.73 | -11,156,321.84 | -10,057,415.08 | -5,662,634.02 |
| 其中:利息费用 | 976,428.73 | 3,417,921.96 | 2,494,275.01 | 1,572,830.53 |
| 其中:利息收入 | 2,063,336.49 | 14,696,057.77 | 12,679,059.62 | 7,198,330.18 |
| 加:公允价值变动收益 | 3,158,836.5 | 14,566,568.73 | 13,498,849.62 | 7,977,178.97 |
| 加:投资收益 | 3,133,484.49 | 10,910,158.34 | 5,549,943.68 | 5,065,150.64 |
| 资产处置收益 | -2,294.24 | 133,286.31 | 13,738.27 | 13,738.27 |
| 资产减值损失(新) | -178,857.05 | -2,626,552.77 | -886,676.47 | -440,520.73 |
| 信用减值损失(新) | -2,312,081.71 | 384,480.59 | -796,396.15 | 1,398,199.62 |
| 其他收益 | 19,672,640.66 | 53,110,690.06 | 35,390,143.2 | 23,075,995.38 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 80,220,974.65 | 241,736,982 | 211,441,893.74 | 144,701,189.66 |
| 加:营业外收入 | 269.18 | 104,220 | 102,137.76 | 12,557.7 |
| 减:营业外支出 | 129,971.22 | 201,545.82 | 81,680.71 | 51,255.85 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 80,091,272.61 | 241,639,656.18 | 211,462,350.79 | 144,662,491.51 |
| 减:所得税费用 | 5,081,187.65 | 15,065,235.61 | 17,746,212.69 | 13,140,746.14 |
| 六、净利润 | 75,010,084.96 | 226,574,420.57 | 193,716,138.1 | 131,521,745.37 |
| 持续经营净利润 | 75,010,084.96 | 226,574,420.57 | 193,716,138.1 | 131,521,745.37 |
| 归属于母公司股东的净利润 | 75,010,084.96 | 226,574,420.57 | 193,716,138.1 | 131,521,745.37 |
| (一)基本每股收益 | 0.63 | 1.89 | 1.61 | 1.1 |
| (二)稀释每股收益 | 0.63 | 1.89 | 1.61 | 1.1 |
| 九、综合收益总额 | 75,010,084.96 | 226,574,420.57 | 193,716,138.1 | 131,521,745.37 |
| 归属于母公司股东的综合收益总额 | 75,010,084.96 | 226,574,420.57 | 193,716,138.1 | 131,521,745.37 |
| 公告日期 | 2024-04-23 | 2024-04-23 | 2023-10-27 | 2023-08-18 |
| 审计意见(境内) | | 标准无保留意见 | | |